Correlation Between Oncolytics Biotech and Ascot Resources

Can any of the company-specific risk be diversified away by investing in both Oncolytics Biotech and Ascot Resources at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncolytics Biotech and Ascot Resources into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oncolytics Biotech and Ascot Resources, you can compare the effects of market volatilities on Oncolytics Biotech and Ascot Resources and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncolytics Biotech with a short position of Ascot Resources. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncolytics Biotech and Ascot Resources.

Diversification Opportunities for Oncolytics Biotech and Ascot Resources

0.7

Correlation Coefficient

Oncolytics Biotech  Ascot Resources

Poor diversification

The 3 months correlation between Oncolytics and Ascot is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and Ascot Resources in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascot Resources and Oncolytics Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncolytics Biotech are associated (or correlated) with Ascot Resources. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascot Resources has no effect on the direction of Oncolytics Biotech i.e., Oncolytics Biotech and Ascot Resources go up and down completely randomly.

Pair Corralation between Oncolytics Biotech and Ascot Resources

Assuming the 90 days trading horizon Oncolytics Biotech is expected to under-perform the Ascot Resources. But the stock apears to be less risky and, when comparing its historical volatility, Oncolytics Biotech is 1.46 times less risky than Ascot Resources. The stock trades about -0.12 of its potential returns per unit of risk. The Ascot Resources is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  25.00  in Ascot Resources on October 26, 2024 and sell it today you would lose (4.00) from holding Ascot Resources or give up 16.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.39%
Values	Daily Returns

Oncolytics Biotech  vs.  Ascot Resources

Oncolytics Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oncolytics Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Ascot Resources

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ascot Resources has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Ascot Resources is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Oncolytics Biotech and Ascot Resources

The main advantage of trading using opposite Oncolytics Biotech and Ascot Resources positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncolytics Biotech position performs unexpectedly, Ascot Resources can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascot Resources will offset losses from the drop in Ascot Resources' long position.

The idea behind Oncolytics Biotech and Ascot Resources pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.